Vadivarhe Speciality Chemicals Ltd (NSE: VSCL) is a Mumbai, Maharashtra-based company in the Custom Synthesis and Specialty CDMO industry. With a market capitalisation of ₹34 Cr, it ranks #4,170 by market cap among the 6,137 Indian listed companies on FinBizNet, and #12 of 13 in Custom Synthesis and Specialty CDMO. The share price is up 0.6% over one year and down 15.5% over three months.
| Market Cap | ₹34 Cr |
|---|---|
| NSE Symbol | VSCL |
| Sector | Materials > Chemicals > Speciality Chemicals |
| Sub-Industry | Specialty Chemicals > Custom Synthesis and Specialty CDMO |
| Return on Equity | -4.99% |
| Return on Assets | -0.97% |
| 52-Week Range | ₹16.05 – ₹31.80 |
| 1-Year Price Change | +0.6% |
| 3-Month Price Change | -15.5% |
| Headquarters | Mumbai, Maharashtra |
| Website | vscl.in |
Vadivarhe Speciality Chemicals Limited manufactures and sells organic chemicals, intermediates, active pharmaceutical ingredients (APIs), personal care products, and specialty chemicals in India and internationally. The company offers intermediates, such as trimethyl ortho propionate, tributyl ortho propionate, trimethyl ortho valerate, trimethyl ortho butyrate, trimethyl ortho benzoate, tributyl ortho valerate, 4-aminomorpholine, and 1-bromo-4-tert butyl benzene. It also provides personal care ingredients comprising sodium thioglycolate powder and calcium thioglycolate powder; and specialty chemicals, including tert-butoxy-bis (dimethyl amino) methane and 3-aminophthalhydrazide sodium salt. In addition, the company offers APIs comprising moxifloxacin hydrochloride IP, ketoprofen, dexketoprofen trometamol, and azelaic acid USP. Further, it provides inorganic chemicals, bio-chemicals, and bulk drugs; and related services. Vadivarhe Speciality Chemicals Limited was incorporated in 2009 a
1. Manufacturing of Speciality Chemicals, Intermediates & API-This segment manufactures organic chemicals, intermediates, active pharmaceutical ingredients, personal care products, and specialty chemicals. 2. Neutraceuticals Products-This segment offers neutraceutical products. 3. Unallocated Corporate Assets-0
1. Manufacturing of Speciality Chemicals, Intermediates & API-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Anupam Rasayan India Ltd | ₹13,389 Cr | 73.6 | 5.76% | ₹655 Cr | -2.2% |
| Neogen Chemicals Limited (Neogen) | ₹7,465 Cr | 227.6 | 3.58% | ₹250 Cr | +45.2% |
| Laxmi Organic Industries Ltd | ₹4,963 Cr | 59.9 | 4.08% | ₹968 Cr | -27.6% |
| Tatva Chintan Pharma Chem Ltd | ₹4,547 Cr | 105.8 | 5.53% | ₹217 Cr | +22.0% |
| Prasol Chemicals Limited | ₹4,476 Cr | 50.7 | — | ₹434 Cr | — |
| Paushak Ltd. | ₹2,046 Cr | 42.9 | 8.22% | ₹84 Cr | — |
| Sunshield Chemicals Ltd. | ₹906 Cr | 27.7 | 17.02% | — | +12.6% |
| Chemcon Speciality Chemicals Limited | ₹803 Cr | 33.4 | 4.80% | ₹65 Cr | -27.6% |
| Vadivarhe Speciality Chemicals Ltd | ₹34 Cr | — | -4.99% | — | +0.6% |
Listed by market capitalisation. Ratios are shown for context only.
Vadivarhe Speciality Chemicals Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Custom Synthesis and Specialty CDMO).
Vadivarhe Speciality Chemicals Ltd has a return on equity of -4.99%.
Vadivarhe Speciality Chemicals Ltd is listed on the NSE under the symbol VSCL.
Vadivarhe Speciality Chemicals Ltd's share price is up 0.6% over one year and down 15.5% over three months. Its 52-week range is ₹16.05 to ₹31.80.
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.